Businesses and individuals grapple with decisions about coverage.

The Wall Street Journal: Businesses Prepare For Health Regulation One of the primary decisions for most companies this year will be how to proceed about their health advantages. They have just 12 months before the main provisions of the federal government overhaul law take influence on Jan. 1, 2014, reshaping health coverage in the U.S. Companies with at least 50 employees will owe penalties if they don't cover full-time employees. Most Americans will encounter a parallel ‘person mandate’ to acquire insurance. And new online marketplaces known as exchanges will sell insurance plans in each state, paired with federal subsidies for lower-income people .WuXi PharmaTech shall provide integrated providers for ARX788, including the development and developing of the toxin, antibody and ADC, pre-clinical development and medical trials.D., CEO of Ambrx. This collaboration allows Ambrx to further lengthen our pipeline of ADCs and gain access to the China marketplace through our partnership with ZMC. Our experience with site-particular ADC technology shows that we possess the potential to generate best-in-class therapeutic applicants, and we look forward to advancing ARX788 into the clinic to comprehend its full potential. Chunbo Li, Chairman of Zhejiang Medicine, commented, We are honored to partner with Ambrx, a respected biotech organization, in ADC medicines. We will work with WuXi PharmaTech to accelerate the development and commercialization of ARX788 in China to bring advantages to Her2-positive cancers patients.